Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins

Cancer Immunology, Immunotherapy

Volumn 53, Issue 12, 2004, Pages 1085-1092

  Pavlenko, Maxim ^a   Roos, Anna Karin ^a   Leder, Christoph ^a   Hansson, Lars Olof ^a   Kiessling, Rolf ^a   Levitskaya, Elena ^a   Pisa, Pavel ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CTL; DNA vaccine; Heat shock protein; Prostate specific antigen

Indexed keywords

CD8 ANTIGEN; CHIMERIC PROTEIN; DNA VACCINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; PLASMID DNA; PLASMID VECTOR; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG POTENCY; ESCHERICHIA COLI; IMMUNIZATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; HEAT-SHOCK PROTEINS; MICE; MICE, INBRED C57BL; PLASMIDS; PROSTATE-SPECIFIC ANTIGEN; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

EID: 8644277992     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0559-z     Document Type: Article

References (28)

1. Armbruster DA (1993) Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 39(2):181-195
2. Barrios C, Georgopoulos C, Lambert PH, Del Giudice G (1994) Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin Exp Immunol 98(2):229-233
3. Chen CH, Wang TL, Hung CF et al (2000) Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 60(4):1035-1042
4. Cheng WF, Hung CF, Chai CY et al (2001) Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J Immunol 166(10):6218-6226
5. Chu NR, Wu HB, Wu T, Boux LJ, Siegel MI, Mizzen LA (2000) Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7. Clin Exp Immunol 121(2):216-225
6. Ciupitu AM, Petersson M, O'Donnell CL et al (1998) Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med 187(5):685-691
7. Hauser H, Chen SY (2003) Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting. Methods 31(3):225-231
8. Hodge JW, Schlom J, Donohue SJ et al (1995) A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate. Int J Cancer 63(2):231-237
9. Hsu KF, Hung CF, Cheng WF et al (2001) Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther 8(5):376-383
10. Karr JF, Kantor JA, Hand PH, Eggensperger DL, Schlom J (1995) The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res 55(11):2455-2462
11. Kim JJ, Trivedi NN, Wilson DM et al (1998) Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. Oncogene 17(24):3125-3135
12. Kim JJ, Yang JS, Nottingham LK et al (2001) Induction of immune responses and safety profiles in Rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen. Oncogene 20(33):4497-4506
13. Liu WJ, Gao F, Zhao KN et al (2002) Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301(1):43-52
14. Lundwall A, Lilja H (1987) Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 214(2):317-322
15. McCormack RT, Rittenhouse HG, Finlay JA et al (1995) Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45(5):729-744
16. Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Muller M (2002) Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294(1):47-59
17. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145(5):907-923
18. Papsidero LD, Kuriyama M, Wang MC et al (1981) Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 66(1):37-42
19. Flanelles L, Thomas MC, Alonso C, Lopez MC (2001) DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 69(10):6558-6563
20. Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269(5230):1585-1588
21. Suzue K, Zhou X, Eisen HN, Young RA (1997) Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci U S A 94(24):13146-13151
22. Tang DC, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356(6365):152-154
23. Trimble C, Lin CT, Hung CF et al (2003) Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21(25-26):4036-4042
24. Udono H, Yamano T, Kawabata Y, Ueda M, Yui K (2001) Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 13(10):1233-1242
25. Ulmer JB, Donnelly JJ, Parker SE et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259(5102):1745-1749
26. Wang MC, Valenzuela LA, Murphy GP, Chu TM (1997) Purification of a human prostate specific antigen. Invest Urol 17(2):159-163
27. Wei C, Storozynsky E, McAdam AJ et al (1996) Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother 42(6):362-368
28. Wolff JA, Malone RW, Williams P et al (1990) Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1):1465-1468